LumiraDx: Emergency Use Authorization, UK OKl for Fast Lab Solutions Multiplex COVID, Flu Assay

 

• LumiraDx SARS-CoV-2 & Flu A/B RNA STAR Complete assay receives Emergency Use Authorization from the FDA along with being successfully validated by the UK Health Security Agency (UKHSA) under the Coronavirus Test Device Approvals (CTDA) process.

• This multiplex test utilizes the innovative qSTAR technology allowing for high-throughput, direct amplification, with highly sensitive results on open molecular platforms.

• LumiraDx SARS-CoV-2 & Flu A/B RNA STAR Complete assay adds to LumiraDx’s expanding portfolio of qSTAR molecular solutions for COVID testing.

https://finance.yahoo.com/news/lumiradx-receives-fda-emergency-authorization-130000701.html